{
    "code": "02025061",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025061",
    "time": "2015-11-20 05:01:33",
    "許可證字號": "衛署藥輸字第025061號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/07\/29",
    "發證日期": "98\/07\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202506101",
    "中文品名": "首利安口服液100毫克\/毫升",
    "英文品名": "Solian Oral Solution 100mg\/ml",
    "適應症": "精神分裂症",
    "劑型": "170內服液劑",
    "包裝": "100毫升以下玻璃瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "AMISULPRIDE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市松山區復興北路337號12、13、14樓",
    "主製造廠": {
        "製造廠名稱": "F150149000  UNITHER LIQUID MANUFACTURING",
        "製造廠廠址": "1-3, ALL'EE DE LA NESTE Z.I. D'EN SIGAL 31770 COLOMIERS FRANCE",
        "製造廠公司地址": "",
        "製造廠國別": "FRANCE",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816401900",
            "成分名稱": "AMISULPRIDE",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Solian Oral Solution_LPI_C_CCDS v9_clean_approved-104-09-14.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025061&Seq=004&Type=9"
        },
        {
            "title": "首利安口服液 英文仿單-103-11-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025061&Seq=003&Type=9"
        },
        {
            "title": "首利安口服液 中文仿單-103-11-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025061&Seq=002&Type=9"
        },
        {
            "title": "020250610001___20120921.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025061&Seq=001&Type=9"
        }
    ]
}